Induction of class II major histocompatibility complex expression in human multiple myeloma cells by retinoid

Haematologica

Volumn 92, Issue 1, 2007, Pages 115-120

  Sanda, Takaomi ^a   Iida, Shinsuke ^a   Kayukawa, Satoshi ^a   Ueda, Ryuzo ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

CIITA; MHC II; Multiple myeloma; Retinoid

Indexed keywords

INTERFERON REGULATORY FACTOR 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TAMIBAROTENE;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; MYELOMA CELL; NUCLEOTIDE SEQUENCE; UPREGULATION;

ANTICARCINOGENIC AGENTS; BENZOATES; CELL LINE, TUMOR; CELL PROLIFERATION; DNA, COMPLEMENTARY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MHC CLASS II; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; JURKAT CELLS; MULTIPLE MYELOMA; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RETINOIDS; TETRAHYDRONAPHTHALENES;

EID: 33846940740     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.10300     Document Type: Article

References (19)

1. Sirohi B, Powles R. Multiple myeloma. Lancet 2004;363:875-87.
2. Iida S, Ueda R. Multistep tumorigenesis of multiple myeloma: its molecular delineation. Int J Hematol 2003;77:207-12.
3. Silacci P, Mottet A, Steimle V, Reith W, Mach B. Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA. J Exp Med 1994;180:1329-36.
4. + T cells and immunosurveillance of B-cell tumors. Proc Natl Acad Sci USA 1994;91:5700-4.
5. Muhlethaler-Mottet A, Otten LA, Steimle V, Mach B. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. Embo J 1997;16:2851-60.
6. Ghosh N, Gyory I, Wright G, Wood J, Wright KL. Positive regulatory domain I binding factor 1 silences class II transactivator expression in multiple myeloma cells. J Biol Chem 2001;276:15264-8.
7. Morris AC, Beresford GW, Mooney MR, Boss JM. Kinetics of a gamma interferon response: expression and assembly of CIITA promoter IV and inhibition by methylation. Mol Cell Biol 2002;22:4781-91.
8. Piskurich JF, Wang Y, Linhoff MW, White LC, Ting JP. Identification of distinct regions of 5′ flanking DNA that mediate constitutive, IFN-γ, STAT1, and TGF-β-regulated expression of the class II transactivator gene. J Immunol 1998;160:233-40.
9. Freemantle SJ, Spinella MJ, Dmitovsky E. Retinoids in cancer therapy and chemoprevention: promise and resistance. Oncogene 2003;22:7305-15
10. Sanda T, Kuwano T, Nakao S, Iida S, Ishida T, Komatsu H, et al. Antimyeloma effects of a novel synthetic retinoid Am80 (Tamibarotene) through inhibition of angiogenesis. Leukemia 2005;19:901-9.
11. Takagi K, Suganuma M, Kagechika H, Shudo K, Ninomiya M, Muto Y, et al. Inhibition of ornithine decarboxylase induction by retinobenzoic acids in relation to their binding affinities to cellular retinoid-binding proteins. J Cancer Res Clin Oncol 1988;114:221-4.
12. Tobita T, Takeshita A, Kitamura K, Ohnishi K, Yanagi M, Hiraoka A, et al. Treatment with a new synthetic retinoid, Am80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid. Blood 1997;90:967-73.
13. Suzuki, A, Iida, S, Kato-Uranishi, M, Tajima, E, Zhan, F, Hanamura, I, et al. ARK5 is transcriptionally regulated by the Large-MAF family and mediates IGF-1-induced cell invasion in multiple myeloma: ARK5 as a new molecular determinant of malignant multiple myeloma. Oncogene 2005;24:6936-44.
14. Sanda T, Asamitsu K, Ogura H, Iida S, Utsunomiya A, Ueda R, et al. Induction of cell death in adult T-cell leukemia cells by a novel IkB kinase inhibitor. Leukemia 2006;20:590-8.
15. Arai M, Kondoh N, Imazaki N, Hada A, Hatsuse K, Kimura F, et al. Transformation-associated gene regulation by ATF6a during hepatocarcinogenesis. FEBS Lett 2006;580:184-90.
16. Sanda T, Iida S, Ogura H, Asamitsu K, Murata T, Bacon, KB, et al. Growth inhibition of multiple myeloma cells by a novel IkB kinase inhibitor. Clin Cancer Res 2005;11:1974-82.
17. Weil R, Israel A. T-cell-receptor- and B-cell-receptor-mediated activation of NF-kappaB in lymphocytes. Curr Opin Immunol 2004;16:374-81.
18. Pelicano L, Li F, Schindler C, Chelbi-Alix MK. Retinoic acid enhances the expression of interferon-induced proteins: evidence for multiple mechanisms of action. Oncogene 1997;15:2349-59.
19. Matikainen S, Ronni T, Hurme M, Pine R, Julkunen I. Retinoic acid activates interferon regulatory factor-1 gene expression in myeloid cells. Blood 1996;88:114-23.